Cardiac electrical abnormalities in a mouse model of left ventricular non-compaction cardiomyopathy
Mutations in MINDBOMB 1 (MIB1), encoding an E3 ubiquitin ligase of the NOTCH signaling pathway, cause left ventricular noncompaction cardiomyopathy (LVNC) in mice and humans, increasing the risk of arrhythmia and left ventricular dysfunction. This study aimed to investigate the effect of MIB1 mutations on cardiac electrical activity. We examined male Mib1flox;Tnnt2Cre mice, a disease model of LVNC, and wildtype littermates on the C57BL/6J genetic background. Our results demonstrate that the gap-junction protein connexin43 was delocalized from the intercalated disks to the lateral long axis of Mib1flox;Tnnt2Cre cardiomyocytes. Cardiomyocyte electrophysiology revealed an increase in the Na (INa) peak density at potentials between -50 and -30 mV in Mib1flox;Tnnt2Cre mice, with no changes in INa activation or inactivation kinetics. Mib1flox;Tnnt2Cre cardiomyocytes also showed decreases in outward K+ peak currents and currents at the end of depolarizing pulses at potentials ≥-10 mV and ≥-20 mV, respectively, and this was accompanied by a lower charge density at ≥-20 mV. Action potential duration was increased in Mib1flox;Tnnt2Cre cardiomyocytes. The cardiac stress, induced by swimming endurance training or β-adrenergic stimulation with isoproterenol, increases QTc duration in Mib1flox;Tnnt2Cre mice, accompanied by a decrease in T-wave amplitude and area. Swimming endurance training decreased heart rate in wildtype and Mib1flox;Tnnt2Cre mice but was unaffected by long-term isoproterenol treatment. These mouse findings are in agreement with an increased QTc duration found in LVNC patients carrying MIB1 mutations. These results provide insight into the outcomes of LVNC and relate its pathogenicity to impaired ventricular repolarization.
Authors
- Juan Ramón Gimeno (ORCID: https://orcid.org/0000-0001-5818-1754)
- Eva Delpón (ORCID: https://orcid.org/0000-0003-4499-8645)
- José Luís de la Pompa (ORCID: https://orcid.org/0000-0001-6761-7265)
- Tania Papoutsi
- Vítor S. Fernandes (ORCID: https://orcid.org/0000-0001-6060-9035)
- Ricardo Caballero (ORCID: https://orcid.org/0000-0002-6424-9687)
- Marcos Siguero-Álvarez (ORCID: https://orcid.org/0000-0003-1945-0178)
Institutions
- Universidad Complutense de Madrid (ES)
- Instituto de Salud Carlos III (ES)
- Spanish National Centre for Cardiovascular Research (ES)
- Hospital Universitario Virgen de la Arrixaca (ES)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1371/journal.pone.0314840
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fundación BBVA
- Sociedad Española de Cardiología
- Comunidad de Madrid
- Ministerio de Ciencia, Innovación y Universidades
- Ministerio de Ciencia e Innovación
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares